BUZZ-U.S. STOCKS ON THE MOVE-Dow Chemical, OHR, BioMarin
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were set to dip at the open on Friday, setting indexes up for a full week of daily declines, as the dollar index added to the previous session's rebound ahead of a speech by Federal Reserve Chair Janet Yellen. Dow Jones industrial average futures were down 0.26 percent at 17,557, S&P 500 futures were down 0.20 percent at 2,044.5 and Nasdaq 100 futures were down 0.23 percent at 4,301.
** OHR PHARMACEUTICAL INC, Thursday close $8.73, -65.75 pct premarket
The company said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy.
** DOW CHEMICAL CO, Thursday close $46.86, +4.35 pct premarket
** OLIN CORP, Thursday close $27.19, +27.69 pct premarket
Dow Chemical said it would separate most of its chlorine business and sell it to smaller rival Olin in a tax-efficient deal valued at about $5 billion.
** OREXIGEN THERAPEUTICS INC, Thursday close $7.25, +7.59 pct premarket
The drugmaker said on Thursday that the European Commission granted marketing authorization to the company's obesity drug, Mysimba. Continued...